Angiotensin II Antagonism of TGF-Beta 1

NCT00320970 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Nephropathy
Hypertension

Interventions

DRUG: Candesartan

Sponsor

Providence Health & Services

Collaborators

[object Object]